Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation
Instead of offering a long list of peptides, we focus on those that are most commonly used and most relevant for real-world goals
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Zepbound vs Wegovy: Different Medications, Different Physiology This comparison is more physiologically meaningful
Parker VE, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper AT, et al
Working with your PlexusDx clinical team, you and your prescriber establish a dosing planwhether weekly, twice-weekly, or another frequencybased on your baseline weight, metabolic health markers, genetic test results, and tolerance profile